{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:31:19Z","timestamp":1794382279052,"version":"4.9.0"},"reference-count":255,"publisher":"Elsevier","isbn-type":[{"value":"9780444520074","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/b978-0-444-52007-4.00007-2","type":"book-chapter","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T04:21:25Z","timestamp":1288930885000},"page":"783-814","source":"Crossref","is-referenced-by-count":44,"title":["Narcolepsy and cataplexy"],"prefix":"10.1016","author":[{"given":"Seiji","family":"Nishino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0001","series-title":"Loss, Grief and Care: Psychosocial Aspects of Narcolepsy","first-page":"1","article-title":"Life effects of narcolepsy: measures of negative impact, social support and psychological well-being","author":"Alaila","year":"1992"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.46.2.393","article-title":"The clinical spectrum of narcolepsy and idiopathic hypersomnia","volume":"46","author":"Aldrich","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0003","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/sleep\/12.6.487","article-title":"Automobile accidents in patients with sleep disorders","volume":"12","author":"Aldrich","year":"1989","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0004","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0301-0082(93)90042-Q","article-title":"The neurobiology of narcolepsy-cataplexy","volume":"41","author":"Aldrich","year":"1993","journal-title":"Prog Neurobiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0005","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.39.11.1505","article-title":"Narcolepsy associated with lesions of the diencephalon","volume":"39","author":"Aldrich","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0006","first-page":"598","article-title":"Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem","volume":"17","author":"Aldrich","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0007","first-page":"620","article-title":"Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy","volume":"20","author":"Aldrich","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0008","series-title":"Diagnostic and Coding Manual","article-title":"ICSD-2 \u2013 International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0009","series-title":"The Eye Opener","first-page":"1","article-title":"Stimulant medication survey","author":"American Narcolepsy Association","year":"1992"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0010","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 983 sleep disorder patients","volume":"22","author":"Anic-Labat","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0011","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1212\/WNL.56.12.1775","article-title":"A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor","volume":"56","author":"Arii","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0012","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1212\/01.WNL.0000147328.15956.B4","article-title":"CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders","volume":"63","author":"Arii","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0013","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/89522","article-title":"A neural circuit for circadian regulation of arousal","volume":"4","author":"Aston-Jones","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0091-3057(76)90298-7","article-title":"Effects of imipramine, chlorimipramine, and fluoxetine on cataplexy in dogs","volume":"5","author":"Babcock","year":"1976","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0015","series-title":"Brain Mechanisms of Sleep","first-page":"199","article-title":"Canine narcolepsy-cataplexy syndrome: evidence for an inherited monoaminergic-cholinergic imbalance","author":"Baker","year":"1985"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0014-4886(82)90038-3","article-title":"Canine model of narcolepsy: genetic and developmental determinants","volume":"75","author":"Baker","year":"1982","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jmg.15.4.254","article-title":"Genetic study of narcoleptic syndrome","volume":"15","author":"Baraitser","year":"1978","journal-title":"J Med Genet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0018","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/brain\/120.8.1423","article-title":"Idiopathic hypersomnia. A series of 42 patients","volume":"120","author":"Bassetti","year":"1997","journal-title":"Brain"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0019","series-title":"Principles and Practice of Sleep Medicine","first-page":"377","article-title":"Kleine Levin syndrome","author":"Billiard","year":"1989"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(85)92072-0","article-title":"Extraordinary association between HLA-DR2 and narcolepsy","volume":"1","author":"Billiard","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0021","series-title":"Sleep\/Wake Disorders: Natural History, Epidemiology and Longterm Evolution","first-page":"171","article-title":"The clinical and polygraphic development of narcolepsy","author":"Billiard","year":"1983"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/sleep\/9.1.167","article-title":"Daytime sleep characterisitcs and their relationships with night sleep in the narcoleptic patient","volume":"9","author":"Billiard","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0023","first-page":"201","article-title":"Elevated antibodies to streptococcal antigens in narcoleptic subjects","volume":"18","author":"Billiard","year":"1989","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0024","doi-asserted-by":"crossref","first-page":"S-54","DOI":"10.1093\/sleep\/17.suppl_8.S54","article-title":"Family studies in narcolepsy","volume":"17","author":"Billiard","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/sleep\/19.9.727","article-title":"The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness","volume":"19","author":"Bishop","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0026","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2004-835069","article-title":"Narcolepsy and syndromes of primary excessive daytime somnolence","volume":"24","author":"Black","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/sleep\/25.7.719","article-title":"Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602","volume":"25","author":"Black","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0028","first-page":"1191","article-title":"HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF IgG reactive to rat hypothalamic protein extract","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0029","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biopsych.2005.04.026","article-title":"Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy","volume":"58","author":"Black","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(87)91045-6","article-title":"Brain dopamine receptor levels elevated in canine narcolepsy","volume":"402","author":"Bowersox","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0031","series-title":"Narcolepsy","first-page":"201","article-title":"The impact of compound narcolepsy on the life of the patient","author":"Broughton","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0032","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/9.1.205","article-title":"Excessive daytime sleepiness and pathophysiology of narcolepsy-cataplexy: a laboratory perspective","volume":"9","author":"Broughton","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0034","first-page":"150","article-title":"A single nap is as accurate as the MSLT in diagnosing EDS in narcolepsy-cataplexy","volume":"17","author":"Broughton","year":"1988","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0013-4694(88)90145-9","article-title":"Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched control","volume":"70","author":"Broughton","year":"1988","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0036","series-title":"Sleep and its Disorders in Children","first-page":"181","article-title":"Narcolepsy and its differential diagnosis","author":"Guilleminault","year":"1987"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0037","series-title":"Principles and Practice of Sleep Medicine","first-page":"549","article-title":"Narcolepsy syndrome","author":"Guilleminault","year":"1994"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneur.1974.00490400069008","article-title":"A study on cataplexy","volume":"31","author":"Guilleminault","year":"1974","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0039","series-title":"Narcolepsy","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0040","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(89)91977-6","article-title":"Familial patterns of narcolepsy","volume":"2","author":"Guilleminault","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0041","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/sleep\/9.4.519","article-title":"Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness","volume":"9","author":"Carskadon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0042","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","article-title":"Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"87","author":"Castelli","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0043","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/sleep\/17.suppl_8.S17","article-title":"Narcolepsy in children","volume":"17","author":"Challamel","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0044","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0013-4694(95)00075-A","article-title":"Correlates of sleep latency on the multiple sleep latency test in a clinical population","volume":"95","author":"Chervin","year":"1995","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0046","first-page":"43","article-title":"Hypnogogic hallucinations associated with sleep onset REM period in narcolepsy-cataplexy","volume":"3","author":"Chetrit","year":"1994","journal-title":"J Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0047","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/sleep\/9.1.250","article-title":"Sleep apnea in narcolepsy","volume":"9","author":"Chokroverty","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0048","first-page":"117","article-title":"Learning and memory in narcoleptic patients and controls","volume":"18","author":"Cohen","year":"1989","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0140-6736(93)92992-3","article-title":"Sleep paralysis","volume":"341","author":"Dahlitz","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0050","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.56.12.1749","article-title":"Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients","volume":"56","author":"Dalal","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-193413010-00001","article-title":"Narcolepsy","volume":"13","author":"Daniels","year":"1934","journal-title":"Medicine"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0052","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.mp.4000911","article-title":"MAO-A and COMT polymorphisms and gene effects in narcolepsy","volume":"6","author":"Dauvilliers","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0053","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0054","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S1388-2457(03)00203-7","article-title":"Clinical aspects and pathophysiology of narcolepsy","volume":"114","author":"Dauvilliers","year":"2003","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0055","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine\u2013Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0056","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0057","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1212\/WNL.62.11.2137","article-title":"A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0058","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.20208","article-title":"A narcolepsy susceptibility locus maps to a 5Mb region of chromosome 21q","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0059","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"De Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0062","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.16.1.18","article-title":"The nature of the narcoleptic sleep attack","volume":"16","author":"Dement","year":"1966","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0060","series-title":"Narcolepsy","first-page":"17","article-title":"Daytime sleepiness and sleep \u201cattacks\u201d","author":"Dement","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0061","first-page":"147","article-title":"The prevalence of narcolepsy II","volume":"2","author":"Dement","year":"1973","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0063","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.peptides.2005.04.004","article-title":"CSF hypocretin-1\/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)","volume":"26","author":"Dohi","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0064","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/jn.1964.27.2.152","article-title":"Temporal patterns of discharge of pyramidal tract neurons during sleep and waking in the monkey","volume":"27","author":"Evarts","year":"1964","journal-title":"J Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0066","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1152\/jn.1965.28.2.216","article-title":"Relation of discharge frequency to conduction velocity in pyramidal tract neurons","volume":"28","author":"Evarts","year":"1965","journal-title":"J Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0067","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410130306","article-title":"Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia","volume":"13","author":"Faull","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0068","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variable in patients with narcolepsy","volume":"81","author":"Frederickson","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0074","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/sleep\/10.3.279","article-title":"High prevalence of isolated sleep paralysis: Kanashibari phenomenon in Japan","volume":"10","author":"Fukuda","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0069","series-title":"The Orexin\/Hypocretin System: Physiology and Pathophysiology","first-page":"367","article-title":"Hypocretin\/orexin replacement therapy in hypocretin\/orexin deficient narcolepsy: an overview","author":"Fujiki","year":"2006"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0070","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00001756-200104170-00026","article-title":"Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation","volume":"12","author":"Fujiki","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0071","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1440-1819.2002.00978.x","article-title":"Analysis of onset location, laterality and propagation of cataplexy in canine narcolepsy","volume":"56","author":"Fujiki","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0072","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","article-title":"Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin ligand deficient narcoleptic dog","volume":"6","author":"Fujiki","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0073","first-page":"A230","article-title":"Wake promoting effects of non-imidazolin histamine H3 antagonist in orexin\/ataxin-3 narcoleptic mice","volume":"29","author":"Fujiki","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/sleep\/17.3.265","article-title":"Stability of cataplexy over several months \u2013information for the design of therapeutic trials","volume":"17","author":"Gelb","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0076","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0987-7053(96)80174-2","article-title":"Diagnosis of narcolepsy-cataplexy: importance of continuous recording in ambulatory EEG. Report of 20 cases","volume":"25","author":"Genton","year":"1995","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0077","series-title":"Sleep '84","first-page":"380","article-title":"Comparison of sleep parameters in narcoleptics with and without periodic movements of sleep","author":"Godbout","year":"1985"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0078","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/archneur.1962.00450210056006","article-title":"Sleep paralysis","volume":"6","author":"Goode","year":"1962","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0079","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0081","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0082","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(82)90835-6","article-title":"Different behaviors during paradoxical sleep without atonia depend on pontine lesion site","volume":"239","author":"Hendricks","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0083","first-page":"282","article-title":"Uber genuine narkolepsie","volume":"30","author":"Henneberg","year":"1916","journal-title":"Neurologisches Zentralblatt"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0084","series-title":"Narcolepsy","first-page":"97","article-title":"Sleep paralysis","author":"Hishikawa","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0085","series-title":"Negative Motor Phenomena","first-page":"245","article-title":"Physiology of REM sleep, cataplexy, and sleep paralysis","author":"Hishikawa","year":"1995"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0013-4694(76)90210-8","article-title":"Sleep satiation in narcoleptic patients","volume":"41","author":"Hishikawa","year":"1976","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0087","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1034\/j.1399-0039.2001.057003230.x","article-title":"Case\u2013control study with narcoleptic patients and healthy controls who, like the patients, possess both HLA-DRB1*1501 and -DQB1*0602","volume":"57","author":"Hohjoh","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0088","first-page":"191","article-title":"Census of narcolepsy, cataplexy and sleep life among teen-agers in Fujisawa city","volume":"8","author":"Honda","year":"1979","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0089","series-title":"HLA in Narcolepsy","first-page":"24","article-title":"Clinical features of narcolepsy","author":"Honda","year":"1988"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0090","series-title":"Handbook of Sleep Disorder","first-page":"217","article-title":"Genetic aspects of narcolepsy","author":"Honda","year":"1990"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0091","series-title":"Sleep\/Wake Disorders: Natural History, Epidemiology and Long Term Evolution","first-page":"198","article-title":"A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband","author":"Honda","year":"1983"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0092","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/sleep\/9.1.254","article-title":"Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients","volume":"9","author":"Honda","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0093","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2","article-title":"Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system","volume":"415","author":"Horvath","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0094","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1073\/pnas.181330998","article-title":"Arousal effect of orexin A depends on activation of the histaminergic system","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0095","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/sleep\/17.suppl_8.S7","article-title":"Epidemiology of narcolepsy","volume":"17","author":"Hublin","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0096","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410350612","article-title":"The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort","volume":"35","author":"Hublin","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0097","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1101\/gr.GR-1610R","article-title":"Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines","volume":"11","author":"Hungs","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0098","first-page":"182","article-title":"Polygraphic studies of nocturnal sleep of narcoleptics II. The effects of some psychotropic drugs on the appearance of paradoxical phases and hypnagogic hallucinations","author":"Jimbo","year":"1963"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0099","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.1984.tb02144.x","article-title":"HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive","volume":"24","author":"Juji","year":"1984","journal-title":"Tissue Antigens"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0013-4694(86)90078-7","article-title":"Evidence for excessive sleepiness in canine narcoleptics","volume":"64","author":"Kaitin","year":"1986","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0101","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.1982.00510150039009","article-title":"Narcolepsy-cataplexy II: Psychosocial consequences and associated psychopathology","volume":"39","author":"Kales","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0102","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0306-4522(00)00239-6","article-title":"Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of d- and l-derivatives in canine narcolepsy","volume":"99","author":"Kanbayashi","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2869.2002.00284.x","article-title":"CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia","volume":"11","author":"Kanbayashi","year":"2002","journal-title":"J Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0104","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1600-0404.1974.tb02796.x","article-title":"A family study of 50 REM narcoleptics","volume":"50","author":"Kessler","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0105","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/WNL.44.11.2101","article-title":"Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride","volume":"44","author":"Khan","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0106","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/sleep\/9.1.102","article-title":"Muscarinic cholinergic receptors and the canine model of narcolepsy","volume":"9","author":"Kilduff","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0107","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1212\/WNL.55.6.894","article-title":"A discrete pontine ischemic lesion could cause REM sleep behavior disorder","volume":"55","author":"Kimura","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0108","first-page":"A91","article-title":"The role of orexin receptor (OX1R) in the regulation of sleep","volume":"23","author":"Kisanuki","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.42.1.229","article-title":"Brain neurotransmitter changes in human narcolepsy","volume":"42","author":"Kish","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0110","first-page":"1052","article-title":"Narcolepsy in a dog and a cat","volume":"162","author":"Knecht","year":"1973","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0447.1942.tb06773.x","article-title":"Familial narcolepsy","volume":"17","author":"Krabbe","year":"1942","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0112","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/sleep\/25.7.733","article-title":"Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status","volume":"25","author":"Krahn","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0113","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/sleep\/26.5.555","article-title":"Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children","volume":"26","author":"Kubota","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0013-4694(85)91073-9","article-title":"Electroencephalographic correlates of cataplectic attacks in narcoleptic canines","volume":"61","author":"Kushida","year":"1985","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0115","first-page":"270","article-title":"Letter to the editor after Dr Aldrich's review on narcolepsy","volume":"324","author":"Kuwata","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0116","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/0303-8467(92)90040-A","article-title":"The Multiple Sleep Latency Test: a paradoxical test?","volume":"94","author":"Lammers","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0117","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/sleep\/16.3.216","article-title":"Gamma-hydroxybutyrate and narcolepsy: a double-blind placebo-controlled study","volume":"16","author":"Lammers","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/sleep\/19.1.75","article-title":"Spontaneous food choice in narcolepsy","volume":"19","author":"Lammers","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0119","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(84)92742-9","article-title":"Genetic markers in narcolepsy","volume":"2","author":"Langdon","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0120","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/sleep\/17.suppl_8.S25","article-title":"Posttraumatic narcolepsy in mild to moderate closed head injury","volume":"17","author":"Lankford","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0121","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/10.6.608","article-title":"Narcolepsy is a rare disease in Israel","volume":"10","author":"Lavie","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0122","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0123","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1523\/JNEUROSCI.1887-05.2005","article-title":"Discharge of identified orexin\/hypocretin neurons across the sleep\u2013waking cycle","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0124","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0125","first-page":"1041","article-title":"Uber Narkolepsie","volume":"49","author":"L\u00f6wenfeld","year":"1902","journal-title":"Munch Med Wochenschr"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(96)00003-0","article-title":"Dopamine D2 receptors quantified in vivo in human narcolepsy","volume":"41","author":"MacFarlane","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.57.3.539","article-title":"Narcolepsy associated with other central nervous system disorders","volume":"57","author":"Malik","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0129","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/sleep\/27.7.1327","article-title":"A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy","volume":"27","author":"Mamelak","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0130","series-title":"HLA in Narcolepsy","first-page":"150","article-title":"Immunological features of narcolepsy in Japan","author":"Matsuki","year":"1988"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0131","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","article-title":"DQ rather than DR gene marks susceptibility to narcolepsy","volume":"339","author":"Matsuki","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0132","first-page":"337","article-title":"[Assessment of the degree of disability in narcolepsy.]","volume":"55","author":"Mayer","year":"1993","journal-title":"Gesundheitswesen"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0133","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-3057(97)00241-4","article-title":"Circadian temperature and activity rhythms in unmedicated narcoleptic patients","volume":"58","author":"Mayer","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0134","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.6188216","article-title":"Narcolepsy: biogenic amine deficits in an animal model","volume":"220","author":"Mefford","year":"1983","journal-title":"Science"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1531-8249(200101)49:1<136::AID-ANA25>3.0.CO;2-M","article-title":"Hypocretin deficiency in familial symptomatic narcolepsy","volume":"49","author":"Melberg","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0136","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0137","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0138","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1389-9457(00)00013-7","article-title":"Perspectives in narcolepsy and hypocretin (orexin) research","volume":"1","author":"Mignot","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0139","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0140","series-title":"Proceedings of the Third Milano International Symposium, September 18\u201319 \u201cSleep, Hormones, and the Immune System\u201d","first-page":"29","article-title":"Is narcolepsy an autoimmune disease?","author":"Mignot","year":"1992"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","author":"Mignot","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0142","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1523\/JNEUROSCI.13-03-01057.1993","article-title":"Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems","volume":"13","author":"Mignot","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0143","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0144","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.S60","article-title":"DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in caucasian and black americans","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0145","series-title":"13th Congress of the European Sleep Research Society","article-title":"HLA studies in sporadic and familial narcolepsy","author":"Mignot","year":"1996"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0146","first-page":"433","article-title":"HLA Class II studies in 509 narcoleptic patients","volume":"26","author":"Mignot","year":"1997","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0147","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA class II studies in 58 non DRB1*15 (DR2) narcoleptic patients with cataplexy","volume":"49","author":"Mignot","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0148","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(05)78496-8","article-title":"Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults","volume":"351","author":"Mignot","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0149","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0151","first-page":"646","article-title":"On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy","volume":"26","author":"Mignot","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0152","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awl079","article-title":"Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults","volume":"129","author":"Mignot","year":"2006","journal-title":"Brain"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0153","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2005.04.035","article-title":"Behavioral correlates of activity in identified hypocretin\/orexin neurons","volume":"46","author":"Mileykovskiy","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0154","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(83)91101-0","article-title":"Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat","volume":"273","author":"Miller","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(90)90328-9","article-title":"CNS monoamines and their metabolites in canine narcolepsy: a replication study","volume":"509","author":"Miller","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0156","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/sleep\/17.suppl_8.S103","article-title":"Evaluation of treatment efficacy in narcolepsy","volume":"17","author":"Mitler","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0157","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(74)90122-8","article-title":"Narcolepsy-cataplexy in a female dog","volume":"45","author":"Mitler","year":"1974","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0158","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0013-4694(82)90142-0","article-title":"Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment in patients with excessive somnolence","volume":"53","author":"Mitler","year":"1982","journal-title":"Electroenchephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0159","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0013-4694(98)00044-3","article-title":"Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs","volume":"107","author":"Mitler","year":"1998","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0160","first-page":"78","article-title":"Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption","volume":"13","author":"Montplaisir","year":"1978","journal-title":"Biol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0161","first-page":"271","article-title":"Streptococcal antibodies in narcolepsy and idiopathic hypersomnia","volume":"18","author":"Montplaisir","year":"1989","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0162","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.43.1_Part_1.55","article-title":"The positive diagnosis of narcolepsy and narcolepsy's borderland","volume":"43","author":"Moscovitch","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0163","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/sleep\/7.2.115","article-title":"Nocturnal REM latency and sleep disturbance in narcolepsy","volume":"7","author":"Mosko","year":"1984","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0164","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/sleep\/16.5.444","article-title":"Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy","volume":"16","author":"Mullington","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/geno.2000.6143","article-title":"Linkage of human narcolepsy with HLA association to chromosome 4p13-q21","volume":"65","author":"Nakayama","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0166","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0167","first-page":"45","article-title":"Heredofamilial aspects of narcolepsy and hypersomnia","volume":"110","author":"Nevsimalova-Bruhova","year":"1972","journal-title":"Schweiz Arch Neurol Neurochir Psychiatr"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0168","series-title":"The Orexin\/Hypocretin System: Physiology and Pathophysiology","first-page":"73","article-title":"Hypocretin measures in the CSF, and blood and brain tissue","author":"Nishino","year":"2006"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0169","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-0082(96)00070-6","article-title":"Pharmacological aspects of human and canine narcolepsy","volume":"52","author":"Nishino","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0171","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1523\/JNEUROSCI.11-09-02666.1991","article-title":"Dopamine D2 mechanisms in canine narcolepsy","volume":"11","author":"Nishino","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0172","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/sleep\/16.8.706","article-title":"Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds","volume":"16","author":"Nishino","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0173","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.15-07-04806.1995","article-title":"Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy","volume":"15","author":"Nishino","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0174","first-page":"444","article-title":"Acetylcholine release and neuronal activity in the basal forebrain of freely-moving narcoleptic Dobermans","volume":"26","author":"Nishino","year":"1997","journal-title":"Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0175","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/smrv.1999.0069","article-title":"Narcolepsy: genetic predisposition and neuropharmacological mechanisms","volume":"4","author":"Nishino","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0177","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0178","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-0102(00)00195-4","article-title":"Is narcolepsy REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans","volume":"38","author":"Nishino","year":"2000","journal-title":"Neurosci Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0179","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(01)02270-4","article-title":"Decreased brain histamine contents in hypocretin\/orexin receptor-2 mutated narcoleptic dogs","volume":"313","author":"Nishino","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"10.1016\/B978-0-444-52007-4.00007-2_bib0181","first-page":"A476","article-title":"CSF histamine content is decreased in hypocretin-deficient human narcolepsy","volume":"25","author":"Nishino","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0182","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1192\/bjp.169.4.459","article-title":"Hypnagogic and hypnopompic hallucinations: pathological phenomena?","volume":"169","author":"Ohayon","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0183","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1212\/WNL.58.12.1826","article-title":"Prevalence of narcolepsy symptomatology and diagnosis in the European general population","volume":"58","author":"Ohayon","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0184","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/sleep\/25.1.27","article-title":"Clinical aspects of narcolepsy-cataplexy across ethnic groups","volume":"25","author":"Okun","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0893-133X(00)00140-8","article-title":"Sulpiride, a D2\/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy","volume":"23","author":"Okura","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0186","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1212\/WNL.57.10.1896","article-title":"Polymorphisms in hypocretin\/orexin pathway genes and narcolepsy","volume":"57","author":"Olafsdottir","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0187","first-page":"S121","article-title":"Frequency of narcolepsy in the population of a French departement","volume":"22","author":"Ondz\u00e9","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0188","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/sleep\/17.suppl_8.S50","article-title":"Life events in the year preceding the onset of narcolepsy","volume":"17","author":"Orellana","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0189","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004691-200103000-00002","article-title":"Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives","volume":"18","author":"Overeem","year":"2001","journal-title":"J Clin Neurophysiol"},{"issue":"Suppl 1","key":"10.1016\/B978-0-444-52007-4.00007-2_bib0190","first-page":"166","article-title":"Secondary narcolepsy in patients with paraneoplastic anti-Ma2 antibodies is associated with hypocretin deficiency","volume":"11","author":"Overeem","year":"2001","journal-title":"J Sleep Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0191","first-page":"525","article-title":"Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings","volume":"172","author":"Parkes","year":"1974","journal-title":"Q J Med"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0192","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1975.tb05830.x","article-title":"Natural history, symptoms and treatment of the narcoleptic syndrome","volume":"52","author":"Parkes","year":"1975","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0193","first-page":"56","article-title":"Cataplexy associated with G\u00e9lineau's disease; effect of clomipramine.]","volume":"123","author":"Passouant","year":"1970","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0194","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups","volume":"1998","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0195","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0196","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0197","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1212\/01.wnl.0000216142.21375.71","article-title":"Narcolepsy-cataplexy associated with precocious puberty","volume":"66","author":"Plazzi","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0198","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/sleep\/9.1.153","article-title":"HLA antigens in narcolepsy and idiopathic central nervous","volume":"9","author":"Poirier","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0199","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0705447","article-title":"Effects of GABA agonists on body temperature regulation in GABA(B1)\u2212\/\u2212 mice","volume":"140","author":"Queva","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0200","series-title":"Narcolepsy","first-page":"669","article-title":"Polygraphic aspects of narcolepsy","author":"Raynal","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0201","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0013-4694(63)90032-4","article-title":"Nocturnal sleep of narcoleptics","volume":"15","author":"Rechtschaffen","year":"1963","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0306-4522(94)90173-2","article-title":"Cholinergic mechanisms in canine narcolepsy: I. Modulation of cataplexy via local drug administration into pontine reticular formation","volume":"59","author":"Reid","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(96)00541-0","article-title":"Local administration of dopaminergic drugs into the ventral tegmental area modulate cataplexy in the narcoleptic canine","volume":"733","author":"Reid","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0204","series-title":"Narcolepsy","first-page":"145","article-title":"Hypnagogic hallucinations","author":"Ribstein","year":"1976"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0013-4694(78)90162-1","article-title":"Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects","volume":"45","author":"Richardson","year":"1978","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0206","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.45.9.1735","article-title":"PET study of human narcolepsy: no increase in striatal dopamine D2-receptors","volume":"45","author":"Rinne","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0207","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/nbdi.2001.0389","article-title":"Hypocretin levels in sporadic and familial cases of canine narcolepsy","volume":"8","author":"Ripley","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0208","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0209","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/9.1.194","article-title":"Alerting effects of naps in patients with narcolepsy","volume":"9","author":"Roehrs","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01376517-198412000-00009","article-title":"Problems and coping strategies identified by narcoleptic patients","volume":"16","author":"Rogers","year":"1984","journal-title":"J Neurosurg Nurs"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0211","first-page":"42","article-title":"Test of memory in narcoleptics","volume":"13","author":"Rogers","year":"1990","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"Molecular and clinical diversity in paraneoplastic immunity to Ma proteins","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000148570","article-title":"Uber das aufreten von halluzinatorisch-kataplektischem angstsyndrom, wachanfallen und ahnlichen storungen bei schizophrenen","volume":"102","author":"Rosenthal","year":"1939","journal-title":"Mschr Psychiatr Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0214","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0163-8343(90)90078-Q","article-title":"Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy","volume":"12","author":"Rosenthal","year":"1990","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0215","series-title":"Narcolepsy and Hypersomnia","author":"Roth","year":"1980"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0216","first-page":"291","article-title":"Depression in narcolepsy and hypersomnia","volume":"116","author":"Roth","year":"1975","journal-title":"Schweiz Arch Neurol Neurochir Psychiatr"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0217","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/sleep\/9.1.243","article-title":"An alternative to the multiple sleep latency test to determine sleepiness in narcolepsy and hypersomnia: polygraphic scores of sleepiness","volume":"9","author":"Roth","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0218","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.43.6.535","article-title":"Autonomic control of cardiovascular reflexes in narcolepsy","volume":"43","author":"Sachs","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0219","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.smrv.2004.07.007","article-title":"Roles of orexin\/hypocretin in regulation of sleep\/wakefulness and energy homeostasis","volume":"9","author":"Sakurai","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0221","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0222","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/29.5.601","article-title":"The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy","volume":"29","author":"Scammell","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0223","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/WNL.56.12.1751","article-title":"Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke","volume":"56","author":"Scammell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0224","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410320103","article-title":"Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder","volume":"32","author":"Schenck","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0225","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(05)74704-8","article-title":"Increased body-mass index in patients with narcolepsy","volume":"355","author":"Schuld","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0226","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-3223(89)90048-6","article-title":"Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures","volume":"26","author":"Scrima","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0227","first-page":"817","article-title":"Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs","volume":"18","author":"Shelton","year":"1995","journal-title":"Sleep"},{"issue":"Suppl","key":"10.1016\/B978-0-444-52007-4.00007-2_bib0228","first-page":"A241","article-title":"Wake promoting effects of thioperamide, a histamine H3 antagonist in orexin\/ataxin-3 narcoleptic mice","volume":"27","author":"Shiba","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0229","series-title":"Principles and Practice of Sleep Medicine","first-page":"120","article-title":"REM sleep","author":"Siegel","year":"2005"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0230","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1925546","article-title":"Neuronal activity in narcolepsy: identification of cataplexy related cells in the medial medulla","volume":"262","author":"Siegel","year":"1991","journal-title":"Science"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0231","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study","volume":"25","author":"Silber","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0232","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)17553-3","article-title":"A functional autoantibody in narcolepsy","volume":"364","author":"Smith","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0233","first-page":"5","article-title":"Kleine\u2013Levin syndrome ethiopathogenesis and treatment","volume":"128","author":"Smolik","year":"1988","journal-title":"Acta Univ Carol Med Monogr"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0234","first-page":"179","article-title":"Narcolepsy in Negroes","volume":"6","author":"Solomon","year":"1945","journal-title":"Dis Nerv Syst"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(83)91145-9","article-title":"Behavioral correlates of dopaminergic activity in freely moving cats","volume":"258","author":"Steinfels","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0236","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0237","series-title":"The Fourth International Symposium on Narcolepsy","first-page":"13","article-title":"An epidemiological study of narcolepsy in Japanese","author":"Tashiro","year":"1994"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0238","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0239","series-title":"Handbook of Sleep Disorders","first-page":"235","article-title":"Treatment of narcolepsy","author":"Thorpy","year":"1990"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0240","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","author":"US Modafinil in Narcolepsy Multicenter Study Group","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0241","first-page":"631","article-title":"Eigenth\u00fcmliche mit Einschl\u00e4fen verbundene Anf\u00e4lle","volume":"7","author":"Westphal","year":"1877","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0242","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1034\/j.1399-0039.2003.00068.x","article-title":"TNFA promoter polymorphisms and narcolepsy","volume":"61","author":"Wieczorek","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0243","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0244","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0245","series-title":"Annual Congress of the Association of Physicians","first-page":"63","article-title":"The narcolepsies","author":"Wilson","year":"1927"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0246","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0247","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","article-title":"Locus coeruleus neurons: cessation of activity during cataplexy","volume":"91","author":"Wu","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0248","doi-asserted-by":"crossref","first-page":"R1079","DOI":"10.1152\/ajpregu.00207.2002","article-title":"Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement","volume":"283","author":"Wu","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0249","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1113\/jphysiol.2003.052134","article-title":"Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs","volume":"554","author":"Wu","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0250","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1006\/bbrc.2001.6318","article-title":"Orexins activate histaminergic neurons via the orexin 2 receptor","volume":"290","author":"Yamanaka","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0251","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.0953-816x.2001.01725.x","article-title":"Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities","volume":"14","author":"Yoshida","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0252","first-page":"320","article-title":"Criteria for the diagnosis of the narcoleptic syndrome","volume":"32","author":"Yoss","year":"1957","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0253","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0025-7125(16)33982-7","article-title":"Narcolepsy","volume":"44","author":"Yoss","year":"1960","journal-title":"Med Clin North Am"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0254","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","article-title":"Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness","volume":"23","author":"Zeitzer","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-444-52007-4.00007-2_bib0256","series-title":"Principles and Practice of Sleep Medicine","first-page":"91","article-title":"Mammalian sleep","author":"Zepelin","year":"2005"}],"container-title":["Handbook of Clinical Neurology","Sleep Disorders"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T22:49:00Z","timestamp":1559774940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444520074000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9780444520074"],"references-count":255,"URL":"https:\/\/doi.org\/10.1016\/b978-0-444-52007-4.00007-2","relation":{},"ISSN":["0072-9752"],"issn-type":[{"value":"0072-9752","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}